author bradley-merrill-thompson 
Mobi Health News
APRIL 11, 2018
About the Author: Bradley Merrill Thompson is a member of the firm at Epstein Becker & Green, P.C. There, he counsels medical device, drug, and combination product companies on a wide range of FDA regulatory, reimbursement, and clinical trial issues.
Health Law Advisor
MARCH 1, 2022
Attorney Bradley Merrill Thompson is the Chairman of the Board and Chief Data Scientist for EBG Advisors and a Member of the Firm at Epstein Becker Green. The opinions expressed in this publication are those of the author.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Health Law Advisor
APRIL 5, 2022
Attorney Bradley Merrill Thompson is the Chairman of the Board and Chief Data Scientist for EBG Advisors and a Member of the Firm at Epstein Becker Green. The opinions expressed in this publication are those of the author.
Health Law Advisor
JUNE 1, 2022
Attorney Bradley Merrill Thompson is the Chairman of the Board and Chief Data Scientist for EBG Advisors and a Member of the Firm at Epstein Becker Green. The opinions expressed in this publication are those of the author.
Health Law Advisor
MAY 3, 2022
Attorney Bradley Merrill Thompson is the Chairman of the Board and Chief Data Scientist for EBG Advisors and a Member of the Firm at Epstein Becker Green. The opinions expressed in this publication are those of the author.
Expert insights. Personalized for you.
49 
Let's personalize your content